Bailey John E. (Jack) Jr.
President and CEO at G1 Therapeutics, Inc.
- Sold, on record
- $923k
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jul 5, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- G1 Therapeutics, Inc.President and CEO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale G1 Therapeutics, Inc.Plan not statedJan 3 2022
Sold 34,125 shares at $10.41 ($355k)
Bailey John E. (Jack) Jr., President and CEO
Sold 12.8% of holdings ($2.8M position)233,208 shares leftFirst sale on recordFiling
- 2 Form 4 sale G1 Therapeutics, Inc.Plan not statedJan 4 +366 days
Sold 37,626 shares at $5.81 ($219k)
Bailey John E. (Jack) Jr., President and CEO
Sold 12% of holdings ($1.8M position)276,282 shares leftFiling
- 3 Form 4 sale G1 Therapeutics, Inc.RoutineJul 5 +182 days
Sold 2,719 shares at $2.45 ($7k)
Bailey John E. (Jack) Jr., President and CEO
10b5-1 planSold 0.6% of holdings ($1.1M position)433,563 shares leftFiling
- 4 Form 4 sale G1 Therapeutics, Inc.No planJan 2 +181 days
Sold 32,983 shares at $3.27 ($108k)
Bailey John E. (Jack) Jr., President and CEO
No 10b5-1 planSold 7.6% of holdings ($1.4M position)400,580 shares left1x usual sizeFiling
- 5 Form 4 sale G1 Therapeutics, Inc.No planJan 3 +1 day
Sold 11,686 shares at $3.12 ($36k)
Bailey John E. (Jack) Jr., President and CEO
No 10b5-1 planSold 2.3% of holdings ($1.6M position)489,594 shares left0.3x usual sizeFiling
- 6 Form 4 sale G1 Therapeutics, Inc.No planMay 13 +131 days
Sold 37,258 shares at $4.79 ($178k)
Bailey John E. (Jack) Jr., President and CEO
No 10b5-1 planSold 7.6% of holdings ($2.3M position)452,336 shares left1.7x usual sizeFiling
- 7 Form 4 sale G1 Therapeutics, Inc.No planJul 5 +53 days
Sold 7,662 shares at $2.51 ($19k)
Bailey John E. (Jack) Jr., President and CEO
No 10b5-1 planSold 1.4% of holdings ($1.4M position)549,674 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jul 5, 2024 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 7,662 | $19k | 1.4% | No plan | SEC |
| May 13, 2024 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 37,258 | $178k | 7.6% | No plan | SEC |
| Jan 3, 2024 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 11,686 | $36k | 2.3% | No plan | SEC |
| Jan 2, 2024 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 32,983 | $108k | 7.6% | No plan | SEC |
| Jul 5, 2023 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 2,719 | $7k | 0.6% | Routine | SEC |
| Jan 4, 2023 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 37,626 | $219k | 12.0% | Plan not stated | SEC |
| Jan 3, 2022 | G1 Therapeutics, Inc. | President and CEO | Form 4 sale | 34,125 | $355k | 12.8% | Plan not stated | SEC |